Literature DB >> 27296015

Utility of volumetric assessment of cervical funneling to predict cerclage failure.

Jessica S Sheng1, Frank P Schubert1, Avinash S Patil1,2.   

Abstract

OBJECTIVE: To assess the utility of cervical funnel volume as a predictor of cerclage failure.
METHODS: We performed a retrospective cohort study of pregnant women with a McDonald cerclage and sonographic evidence of cervical funneling between 1/2008 and 2/2014. Funnel volume (FV) was calculated and used as a correction factor for cervical length (CL) or cerclage height (CH). Receiver operating characteristic (ROC) curves were used to compare the predictive value of CL, CL:FV, CH and CH:FV for cerclage failure at <28 or <34 weeks. CL:FV was further stratified to the <5th, <10th and >10th percentiles and analyzed for prediction of preterm delivery.
RESULTS: Subjects with cerclage failure (n = 30) delivered at a mean gestational age of 29.8 +/- 5.3 weeks compared to 38.1+/- 1.39 weeks in those without failure (n = 27; p < 0.001). ROC curves demonstrated CL:FV was the best predictor of delivery <28 weeks (AUC 0.80), while CL was the best predictor of delivery <34 weeks (AUC 0.76). Stratification of CL:FV into <5th versus >10th percentile groups was predictive of early preterm delivery (25.1 weeks versus 34 weeks, p = 0.01).
CONCLUSIONS: Volumetric assessment of cervical funneling may improve prediction of cerclage failure in the mid-trimester.

Entities:  

Keywords:  Cerclage; cervix; preterm delivery

Mesh:

Year:  2016        PMID: 27296015     DOI: 10.1080/14767058.2016.1201470

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Anterior uterocervical angle measurement improves prediction of cerclage failure.

Authors:  J C Knight; E Tenbrink; J Sheng; A S Patil
Journal:  J Perinatol       Date:  2017-01-05       Impact factor: 2.521

2.  Correlation Between Clinical Factors and Pregnancy Outcome Following Repeat Cerclage: A Retrospective Analysis of a Chinese Population.

Authors:  Benshuo Cai; Yajun Xia; Xinni Na
Journal:  Front Med (Lausanne)       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.